You can buy or sell CBMG and other stocks, options, ETFs, and crypto commission-free!
Cellular Biomedicine Group, Inc. Common Stock, also called Cellular Biomedicine Group, is a clinical stage biopharmaceutical company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. Read More Its technology includes immune system therapy for treatment of cancer indications and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases. The company was founded in 2009 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Expected Aug 6, After Hours